These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12420156)

  • 1. Buspirone decreases physiological reactivity to unconditioned and conditioned aversive stimuli.
    Bond AJ; Wingrove J; Baylis M; Dalton J
    Psychopharmacology (Berl); 2003 Jan; 165(3):291-5. PubMed ID: 12420156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of buspirone with diazepam and fluvoxamine on aversive classical conditioning in humans.
    Hellewell JS; Guimaraes FS; Wang M; Deakin JF
    J Psychopharmacol; 1999; 13(2):122-7. PubMed ID: 10475716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying the 5-HT1A agonist action of buspirone in man.
    Bridge MW; Marvin G; Thompson CE; Sharma A; Jones DA; Kendall MJ
    Psychopharmacology (Berl); 2001 Nov; 158(3):224-9. PubMed ID: 11713611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of d-fenfluramine on human experimental anxiety.
    Hetem LA; de Souza CJ; Guimarães ES; Zuardi AW; Graeff FG
    Psychopharmacology (Berl); 1996 Oct; 127(3):276-82. PubMed ID: 8912406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diazepam suppresses the acquisition but not the expression of 'fear-potentiation' of the acoustic startle response in man.
    Scaife JC; Langley RW; Bradshaw CM; Szabadi E
    J Psychopharmacol; 2005 Jul; 19(4):347-56. PubMed ID: 15982989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indorenate produces antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors.
    Martínez-Mota L; Estrada-Camarena E; López-Rubalcava C
    Psychopharmacology (Berl); 2002 Dec; 165(1):60-6. PubMed ID: 12474119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lorazepam on fear-potentiated startle responses in man.
    Graham SJ; Scaife JC; Langley RW; Bradshaw CM; Szabadi E; Xi L; Crumley T; Calder N; Gottesdiener K; Wagner JA
    J Psychopharmacol; 2005 May; 19(3):249-58. PubMed ID: 15888510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated cortisol administration attenuates the EEG response to buspirone in healthy volunteers: evidence for desensitization of the 5-HT1A autoreceptor.
    McAllister-Williams RH; Massey AE; Fairchild G
    J Psychopharmacol; 2007 Nov; 21(8):826-32. PubMed ID: 17715208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buspirone, but not sumatriptan, induces miosis in humans: relevance for a serotoninergic pupil control.
    Fanciullacci M; Sicuteri R; Alessandri M; Geppetti P
    Clin Pharmacol Ther; 1995 Mar; 57(3):349-55. PubMed ID: 7697953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of buspirone on gastric sensorimotor function in man.
    Van Oudenhove L; Kindt S; Vos R; Coulie B; Tack J
    Aliment Pharmacol Ther; 2008 Dec; 28(11-12):1326-33. PubMed ID: 18793342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.
    Haleem DJ; Samad N; Haleem MA
    Pharmacol Biochem Behav; 2007 May; 87(1):115-21. PubMed ID: 17498786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic buspirone treatment normalizes regional serotonin synthesis in the olfactory bulbectomized rat brain: an autoradiographic study.
    Watanabe A; Hasegawa S; Nishi K; Nguyen KQ; Diksic M
    Brain Res Bull; 2006 Mar; 69(2):101-8. PubMed ID: 16533657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans.
    McAllister-Williams RH; Massey AE
    Psychopharmacology (Berl); 2003 Mar; 166(3):284-93. PubMed ID: 12589521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers.
    Blonski W; Vela MF; Freeman J; Sharma N; Castell DO
    J Clin Gastroenterol; 2009 Mar; 43(3):253-60. PubMed ID: 18987553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The partial 5-hydroxytryptamine1A receptor agonist buspirone does not antagonize morphine-induced respiratory depression in humans.
    Oertel BG; Schneider A; Rohrbacher M; Schmidt H; Tegeder I; Geisslinger G; Lötsch J
    Clin Pharmacol Ther; 2007 Jan; 81(1):59-68. PubMed ID: 17186000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of buspirone and alprazolam treatment on the startle-potentiated startle response.
    Commissaris RL; Fomum EA; Leavell BJ
    Depress Anxiety; 2004; 19(3):146-51. PubMed ID: 15129416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The characteristics of the pharmacological action of buspirone].
    Dzhagatspanian IA; Asrian AB
    Eksp Klin Farmakol; 1994; 57(1):5-8. PubMed ID: 8142866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic buspirone treatment normalizes open field behavior in olfactory bulbectomized rats: assessment with a quantitative autoradiographic evaluation of the 5-HT1A binding sites.
    Sato H; Skelin I; Debonnel G; Diksic M
    Brain Res Bull; 2008 Mar; 75(5):545-55. PubMed ID: 18355630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.
    Lee ST; Park JH; Kim M
    Headache; 2005 Sep; 45(8):1004-11. PubMed ID: 16109114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal response to buspirone is not impaired in major depression.
    Navinés R; Gómez-Gil E; Martín-Santos R; de Osaba MJ; Escolar G; Gastó C
    Hum Psychopharmacol; 2007 Aug; 22(6):389-95. PubMed ID: 17563921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.